BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6194396)

  • 1. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.
    Barroso A; Alpert E
    Lab Res Methods Biol Med; 1983; 7():153-7. PubMed ID: 6194396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers for hepatoma and carcinoma of biliary tract].
    Higashino K
    Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of tumor markers in clinical oncology].
    Gericke D; Drahovsky D
    Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor markers of hepatocellular carcinoma with special reference to diagnostic efficacy of combination of these markers and relation to its stages].
    Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M
    Gan No Rinsho; 1983 May; 29(6):672-7. PubMed ID: 6192267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
    Shi X; Zhou Y; Xia L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma].
    Iwamoto I; Furukawa M; Ito S; Nakata T; Tanigawa M; Koga Y; Magari Y
    Gan No Rinsho; 1988 Feb; 34(2):208-12. PubMed ID: 2450213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Tsude K; Sakai M; Sato T
    Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
    Weber P; Weberová D; Martínek K
    Neoplasma; 1988; 35(5):605-13. PubMed ID: 2464143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is a tumor marker a laboratory test?
    Galen RS
    Ann Clin Lab Sci; 1977; 7(1):51-6. PubMed ID: 65149
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroxine-binding globulin as a marker of liver tumors.
    Terui S; Moriya Y; Yamamoto H; Koyama Y
    Cancer Detect Prev; 1987; 10(5-6):371-8. PubMed ID: 2436781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcino-fetal antigens].
    Endo Y
    Nihon Rinsho; 1996 Jun; 54(6):1499-504. PubMed ID: 8691600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
    Imoto M; Nishimura D; Fukuda Y; Sugiyama K; Kumada T; Nakano S
    Am J Gastroenterol; 1985 Nov; 80(11):902-6. PubMed ID: 2413756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
    Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
    Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic value of 5'-nucleotide phosphodiesterase isozyme-V for detection of liver metastasis in patients with gastro-intestinal cancer.
    Tomoda H; Furusawa M; Ichino M
    Jpn J Clin Oncol; 1983 Jun; 13(2):353-60. PubMed ID: 6310182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory findings in tumor patients. II].
    Wolff J; Anger G
    Z Arztl Fortbild (Jena); 1980 May; 74(10):469-73. PubMed ID: 6158804
    [No Abstract]   [Full Text] [Related]  

  • 18. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
    Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
    J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.